Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Boehringer Ingelheim
Express Scripts
Cerilliant
Julphar
Mallinckrodt
Farmers Insurance
Daiichi Sankyo
McKesson

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,051,141

« Back to Dashboard

Summary for Patent: 4,051,141
Title: Thieno[3,2-c]pyridine derivatives
Abstract:Thieno[3,2-c]pyridine derivatives having the formula: ##STR1## in which X is S; R is a phenyl or benzoyl radical optionally substituted with 1-3 halogen atoms or lower alkyl, lower alkoxy, hydroxy or nitro; R.sub.1 is hydrogen, halogen, hydroxy or lower alkyl; R.sub.2 is hydrogen or halogen and n is 1 or 2, and in which the symbols R.sub.1 may be different in each CHR.sub.1 when n is 2; and their pharmaceutically acceptable acid addition salts. Said derivatives are therapeutically useful for their anti-inflammatory, vasodilatator and blood plate aggregation inhibitor action.
Inventor(s): Castaigne; Albert Rene Joseph (Toulouse, FR)
Assignee: Centre d'Etudes pour l'Industrie pharmaceutique (Toulouse, FR)
Application Number:05/660,248
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 4,051,141

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,051,141

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France73.03503Feb 1, 1973

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Accenture
Cerilliant
Argus Health
Dow
Chinese Patent Office
Deloitte
Daiichi Sankyo
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.